These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21701074)

  • 1. PON-dering differences in HDL function in coronary artery disease.
    Mineo C; Shaul PW
    J Clin Invest; 2011 Jul; 121(7):2545-8. PubMed ID: 21701074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.
    Besler C; Heinrich K; Rohrer L; Doerries C; Riwanto M; Shih DM; Chroni A; Yonekawa K; Stein S; Schaefer N; Mueller M; Akhmedov A; Daniil G; Manes C; Templin C; Wyss C; Maier W; Tanner FC; Matter CM; Corti R; Furlong C; Lusis AJ; von Eckardstein A; Fogelman AM; Lüscher TF; Landmesser U
    J Clin Invest; 2011 Jul; 121(7):2693-708. PubMed ID: 21701070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.
    Kratzer A; Giral H; Landmesser U
    Cardiovasc Res; 2014 Aug; 103(3):350-61. PubMed ID: 24935432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.
    Riwanto M; Rohrer L; Roschitzki B; Besler C; Mocharla P; Mueller M; Perisa D; Heinrich K; Altwegg L; von Eckardstein A; Lüscher TF; Landmesser U
    Circulation; 2013 Feb; 127(8):891-904. PubMed ID: 23349247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against HDL Components in Ischaemic Stroke and Coronary Artery Disease.
    Batuca JR; Amaral MC; Favas C; Justino GC; Papoila AL; Ames PRJ; Alves JD
    Thromb Haemost; 2018 Jun; 118(6):1088-1100. PubMed ID: 29723873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-atherogenic effects of high-density lipoprotein on nitric oxide synthesis in the endothelium.
    Andrews KL; Moore XL; Chin-Dusting JP
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):736-42. PubMed ID: 20374256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet.
    Terasaka N; Yu S; Yvan-Charvet L; Wang N; Mzhavia N; Langlois R; Pagler T; Li R; Welch CL; Goldberg IJ; Tall AR
    J Clin Invest; 2008 Nov; 118(11):3701-13. PubMed ID: 18924609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet-induced weight loss in overweight or obese women and changes in high-density lipoprotein levels and function.
    Aicher BO; Haser EK; Freeman LA; Carnie AV; Stonik JA; Wang X; Remaley AT; Kato GJ; Cannon RO
    Obesity (Silver Spring); 2012 Oct; 20(10):2057-62. PubMed ID: 22402736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes is associated with loss of HDL endothelium protective functions.
    Vaisar T; Couzens E; Hwang A; Russell M; Barlow CE; DeFina LF; Hoofnagle AN; Kim F
    PLoS One; 2018; 13(3):e0192616. PubMed ID: 29543843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL-Mediated Lipid Influx to Endothelial Cells Contributes to Regulating Intercellular Adhesion Molecule (ICAM)-1 Expression and eNOS Phosphorylation.
    Muñoz-Vega M; Massó F; Páez A; Vargas-Alarcón G; Coral-Vázquez R; Mas-Oliva J; Carreón-Torres E; Pérez-Méndez Ó
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression.
    Kuvin JT; Rämet ME; Patel AR; Pandian NG; Mendelsohn ME; Karas RH
    Am Heart J; 2002 Jul; 144(1):165-72. PubMed ID: 12094204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High density lipoprotein from patients with valvular heart disease uncouples endothelial nitric oxide synthase.
    Chang FJ; Yuan HY; Hu XX; Ou ZJ; Fu L; Lin ZB; Wang ZP; Wang SM; Zhou L; Xu YQ; Wang CP; Xu Z; Zhang X; Zhang CX; Ou JS
    J Mol Cell Cardiol; 2014 Sep; 74():209-19. PubMed ID: 24887036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high-density lipoprotein on endothelium-dependent vasorelaxation.
    McAllister RM; Morris DM; Weimer CM; Laughlin MH
    Appl Physiol Nutr Metab; 2010 Jun; 35(3):319-27. PubMed ID: 20555376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY; Gümüşlü S; Semiz E
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase.
    Yuhanna IS; Zhu Y; Cox BE; Hahner LD; Osborne-Lawrence S; Lu P; Marcel YL; Anderson RG; Mendelsohn ME; Hobbs HH; Shaul PW
    Nat Med; 2001 Jul; 7(7):853-7. PubMed ID: 11433352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner.
    Gong M; Wilson M; Kelly T; Su W; Dressman J; Kincer J; Matveev SV; Guo L; Guerin T; Li XA; Zhu W; Uittenbogaard A; Smart EJ
    J Clin Invest; 2003 May; 111(10):1579-87. PubMed ID: 12750408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial nitric oxide synthase gene Glu298Asp polymorphism in patients with coronary artery disease.
    Salimi S; Firoozrai M; Zand H; Nakhaee A; Shafiee SM; Tavilani H; Mohebbi A
    Ann Saudi Med; 2010; 30(1):33-7. PubMed ID: 20103956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Shen Y; Ding FH; Sun JT; Pu LJ; Zhang RY; Zhang Q; Chen QJ; Shen WF; Lu L
    Cardiovasc Diabetol; 2015 May; 14():52. PubMed ID: 25964115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target.
    Lüscher TF; Landmesser U; von Eckardstein A; Fogelman AM
    Circ Res; 2014 Jan; 114(1):171-82. PubMed ID: 24385510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.